Bragar Eagel & Squire, P.C. Is Investigating Organon, - GlobeNewswire
22 hours ago • Google News
Aldeyra The (ALDX)
US$ 6.059918.59%
Price Chart
Key Statistics
Market Cap
$ 129.57M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
1.4M
52W High
$ 7.20
52W Low
$ 1.14
Dividend Yield
0.00%
Beta
0.90
Technicals
50-Day MA
3.9983
200-Day MA
4.9642
52 Week High
7.2
52 Week Low
1.14
About ALDX
Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.
Employees
9
Headquarters
Lexington, MA
CEO
Dr. Todd C. Brady M.D., Ph.D.
Latest News
Critical Phase 3 Results: Aldeyra's Dry Eye Drug Reproxalap Data Release Tomorrow - Stock Titan
2 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg